Skip to main content

Cortexyme Inc. Common Stock (CRTX)

About The Company

CRTX Stock Market Logo

Cortexyme Inc is a clinical-stage biopharmaceutical company developing a disease-modifying therapeutic approach to treat Alzheimer’s and other degenerative diseases. Its approach is based on the seminal discovery of the presence of Porphyromonas gingivalis or P. gingivalis, and its secreted toxic virulence factor proteases called gingipains. The company operates in only one reportable segment that is developing and commercializing therapeutics.

IPO Year Sector Industry
2019 Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Cortexyme Inc. (CRTX) Latest News

Company Contact & Address (CRTX)

Corporate Headquarters Phone Website
United States
+1 415 910-5717 Official CRTX Website

CRTX Key Executives

Ownership and management information.

Key Data Points*

Exchange Not Available Market Cap Not Available
Sector Health Care P/E Ratio Not Available
Industry Biotechnology: Biological Products (No Diagnostic Substances) Forward P/E 1 Yr. Not Available
1 Year Target Not Available Earnings Per Share (EPS) Not Available
Today’s High/Low Not Available Annualized Dividend Not Available
Share Volume Not Available Ex Dividend Date Not Available
Average Volume Not Available Dividend Pay Date Not Available
Previous Close Not Available Current Yield Not Available
52 Week High/Low Not Available Beta Not Available

* Information and data may delayed

Officers & Directors @ CRTX

Jobs & Employment at Cortexyme Inc.

LinkedIn Company Page
Official Career & Employment Page Careers & Employment at Cortexyme Inc. (CRTX)

Related & Similar Stock Symbols

CTDD Stock Market Price & News


Qwest Corporation 6.75% Notes due 2057

VRRM Stock Market Price & News


Verra Mobility Corporation Class A Common Stock

STG Stock Market Price & News


Sunlands Technology Group American Depositary Shares representing …